Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Comparison of Power Wheelchair Driving Performance Under Immersive and Non-immersive Conditions With Drivers With Neurological Disorders (SIMADAPT2)

29. Oktober 2021 aktualisiert von: Pôle Saint Hélier

Comparison of Power Wheelchair Driving Performance in a Physical Simulator With CAVE, Immersive Helmet and Non-immersive Screen in a Population of Drivers With Neurological Disorders: Pilot Study

This study aims to assess the impact of the choice of visual feedback solution (immersive via CAVE and VR headset; non-immersive via screen only) on driving performance and quality of experience on a physical driving simulator and its acceptability to wheelchair drivers with neurological disorders.

Studienübersicht

Detaillierte Beschreibung

The device under investigation is an electric wheelchair driving simulation solution driving simulation solution for electric wheelchairs, based on a physical physical simulation device that integrates software allowing virtual virtual immersion. This device will be coupled with three visual simulation solutions: a virtual reality helmet, a CAVE (virtual reality room where video virtual reality room where video projectors display content on four sides) and a non-immersive projection (screen only, non-immersive virtual reality solution).

This device is intended to allow patients who may acquire a power wheelchair to train in a virtual environment, which is conducive to the safety of the training, its repetition, and to produce more varied training environments, richer and more adapted to specific and individualised needs. These solutions could facilitate access to real driving for patients who are currently experiencing learning difficulties.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

25

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Bretagne
      • Rennes, Bretagne, Frankreich, 35000
        • Pôle Saint-Hélier

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Male or female, over 18 years of age,
  • Patient with neurological disorders such as brain injury or neurodegeneration,
  • Having been prescribed an electric wheelchair and circulating in electric wheelchair for more than 3 months
  • Of which electric wheelchair is the main mode of travel
  • Whose physical measurements (weight, height) are compatible with the use of the physical simulator chosen for the development of the robotic assistance module, i.e. according to the manufacturer's data 140 kg max and 51 cm max seat width.
  • Having freely consented to participate in the study,
  • In the case of curatorship, having read the patient information document and given his/her free and informed consent to participate in the study, in the presence of his/her curator,
  • In the case of a guardianship, the legal representative having read the information document intended for the legal guardian of an adult under legal protection (under guardianship) and given his or her free and informed consent for the person for whom he or she is responsible to participate in the study (in agreement with the patient)

Exclusion Criteria:

  • Comprehension problems that prevent the protocol from being carried out,
  • Motor disorders of the upper limb requiring additional technical driving assistance,
  • A patient who has expressed difficulties with internal and/or external driving safety on the basis of the WST,
  • Patients who were included in the SIMADAPT1 study to avoid bias due to their experience in the simulator and virtual reality,
  • Pregnant, parturient or breastfeeding women,
  • Person deprived of liberty by a judicial or administrative decision, persons under psychiatric care or for purposes other than research,
  • Minor,
  • Person in emergency situation unable to give prior consent.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Immersive condition
Performance driving wheelchair in immersive condition (in Cave automatic environment or with HMD)
Driving course with obstacles in a CAVE system
Driving course with obstacles with a virtual reality headset
Experimental: Non Immersive condition
Performance driving wheelchair in non immersive condition (with screen and physical simulator or screen only)
Driving course with obstacles on a screen with physical simulator
Driving course with obstacles on a screen only

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
number of the collisions with the environment on the standardised circuit
Zeitfenster: During the driving course, from the beginning to the end of the circuit.

It will be compared in 4 conditions :

  • immersive 1: physical simulator and CAVE_condition A1
  • immersive 2: physical simulator and virtual reality helmet_condition A2
  • non-immersive 1: screen and physical simulator_condition B1
  • non-immersive 2: screen only without simulator_condition B2 Day 1 : A + B Day 8 : A + B
During the driving course, from the beginning to the end of the circuit.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
the time taken to complete the course
Zeitfenster: During the driving course, from the beginning to the end of the circuit.
It will be measured, in minutes and seconds, under the various conditions
During the driving course, from the beginning to the end of the circuit.
evaluation of driving performance with Wheelchair Skill Test (WST-Q-T 5.1)
Zeitfenster: Immediately after intervention

The Wheelchair Skill Test (WST-Q-T 5.1) will be completed by two evaluators after each condition.

The score will be between 0 to 22, a high score will represent a good driving performance

Immediately after intervention
visual information (VICON® system)
Zeitfenster: During the driving course, from the beginning to the end of the circuit.
The number of head movement will be measured by VICON system.
During the driving course, from the beginning to the end of the circuit.
the cognitive load of carrying out the circuit with National Aeronautics and Space Administration Task Load Index
Zeitfenster: Immediately after intervention
The cognitive load of tests under each conditions will be measured by the NASA-Task Load Index. It is in the form of six scales where the participant must assign a score between zero and one hundred to each of them, score indicating a growing level of intensity. Three dimensions relate to the demands imposed on the subject (mental, physical and temporal demands) and three to the interaction of a subject with the task (effort, frustration and performance)
Immediately after intervention
sensation of immersion and the feeling of presence in a virtual situation (Igroup Presence Questionnaire IPQ)
Zeitfenster: Immediately after intervention
It will be evaluated and compared by Igroup Presence Questionnaire IPQ.
Immediately after intervention
discomfort of driving in immersive reality,
Zeitfenster: Immediately after intervention

The occurrence of kinetosis will be evaluated with Graybiel score by the two evaluators after each passage in each condition.

The score is between 1 to 50. A high score shows the patient's discomfort.

Immediately after intervention
satisfaction of the testers and the acceptability of the various conditions simulated
Zeitfenster: Immediately after intervention
Patients will be asked to rate their satisfaction on a scale of 0 to 10, with 10 being very satisfied.
Immediately after intervention
the acceptability of the various conditions simulated
Zeitfenster: Immediately after intervention
Evaluation of acceptability with Unified Theory of Acceptance and Use of Technology (UTAUT) after each condition
Immediately after intervention

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Mitarbeiter

Ermittler

  • Hauptermittler: Philippe GALLIEN, Pole Saint Helier

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

10. Mai 2021

Primärer Abschluss (Tatsächlich)

26. Oktober 2021

Studienabschluss (Tatsächlich)

26. Oktober 2021

Studienanmeldedaten

Zuerst eingereicht

3. Mai 2021

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

17. Mai 2021

Zuerst gepostet (Tatsächlich)

20. Mai 2021

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

1. November 2021

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

29. Oktober 2021

Zuletzt verifiziert

1. Mai 2021

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren